These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26537685)

  • 21. HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants.
    Smith JL; Izumi T; Borbet TC; Hagedorn AN; Pathak VK
    J Virol; 2014 Sep; 88(17):9893-908. PubMed ID: 24942576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Binding Interface between Human APOBEC3F and HIV-1 Vif Elucidated by Genetic and Computational Approaches.
    Richards C; Albin JS; Demir Ö; Shaban NM; Luengas EM; Land AM; Anderson BD; Holten JR; Anderson JS; Harki DA; Amaro RE; Harris RS
    Cell Rep; 2015 Dec; 13(9):1781-8. PubMed ID: 26628363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.
    Zhang W; Huang M; Wang T; Tan L; Tian C; Yu X; Kong W; Yu XF
    Cell Microbiol; 2008 Aug; 10(8):1662-75. PubMed ID: 18419775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.
    Liu B; Sarkis PT; Luo K; Yu Y; Yu XF
    J Virol; 2005 Aug; 79(15):9579-87. PubMed ID: 16014920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis.
    Lavens D; Peelman F; Van der Heyden J; Uyttendaele I; Catteeuw D; Verhee A; Van Schoubroeck B; Kurth J; Hallenberger S; Clayton R; Tavernier J
    Nucleic Acids Res; 2010 Apr; 38(6):1902-12. PubMed ID: 20015971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity.
    Yamashita T; Nomaguchi M; Miyake A; Uchiyama T; Adachi A
    Microbes Infect; 2010 Feb; 12(2):166-71. PubMed ID: 19944180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism.
    Marin M; Golem S; Rose KM; Kozak SL; Kabat D
    J Virol; 2008 Jan; 82(2):987-98. PubMed ID: 17977970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.
    Han Y; Wang X; Dang Y; Zheng YH
    PLoS Pathog; 2008 Jul; 4(7):e1000095. PubMed ID: 18604271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping Region of Human Restriction Factor APOBEC3H Critical for Interaction with HIV-1 Vif.
    Nakashima M; Tsuzuki S; Awazu H; Hamano A; Okada A; Ode H; Maejima M; Hachiya A; Yokomaku Y; Watanabe N; Akari H; Iwatani Y
    J Mol Biol; 2017 Apr; 429(8):1262-1276. PubMed ID: 28336404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 Vif interaction with APOBEC3 deaminases and its characterization by a new sensitive assay.
    Cadima-Couto I; Saraiva N; Santos AC; Goncalves J
    J Neuroimmune Pharmacol; 2011 Jun; 6(2):296-307. PubMed ID: 21279453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the DNA sequence/length and pH on deaminase activity, as well as the roles of the amino acid residues around the catalytic center of APOBEC3F.
    Wan L; Nagata T; Katahira M
    Phys Chem Chem Phys; 2018 Jan; 20(5):3109-3117. PubMed ID: 28825755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Structural Interface between HIV-1 Vif and Human APOBEC3H.
    Ooms M; Letko M; Simon V
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.
    Dang Y; Wang X; Zhou T; York IA; Zheng YH
    J Virol; 2009 Sep; 83(17):8544-52. PubMed ID: 19535447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFβ recruitment and A3G suppression.
    Zhou X; Han X; Zhao K; Du J; Evans SL; Wang H; Li P; Zheng W; Rui Y; Kang J; Yu XF
    J Virol; 2014 Mar; 88(5):2555-63. PubMed ID: 24352440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1.
    Jaguva Vasudevan AA; Hofmann H; Willbold D; Häussinger D; Koenig BW; Münk C
    J Mol Biol; 2017 Apr; 429(8):1171-1191. PubMed ID: 28315663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif.
    Lassen KG; Wissing S; Lobritz MA; Santiago M; Greene WC
    J Biol Chem; 2010 Sep; 285(38):29326-35. PubMed ID: 20624919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.
    Chaipan C; Smith JL; Hu WS; Pathak VK
    J Virol; 2013 Jan; 87(1):444-53. PubMed ID: 23097438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 Vif N-terminal motif is required for recruitment of Cul5 to suppress APOBEC3.
    Evans SL; Schön A; Gao Q; Han X; Zhou X; Freire E; Yu XF
    Retrovirology; 2014 Jan; 11():4. PubMed ID: 24422669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of HIV-1 Vif regions required for CBF-β interaction and APOBEC3 suppression.
    Wang H; Liu B; Liu X; Li Z; Yu XF; Zhang W
    PLoS One; 2014; 9(5):e95738. PubMed ID: 24810617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.
    Albin JS; Haché G; Hultquist JF; Brown WL; Harris RS
    J Virol; 2010 Oct; 84(19):10209-19. PubMed ID: 20686027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.